The Disease Course of Untreated Patients with Thymidine Kinase 2 Deficiency (TK2d) Aged ≤12 Years at TK2d Symptom Onset: Findings from the Largest International TK2d Dataset (P10-6.007)
To characterize the disease course of untreated patients with thymidine kinase 2 deficiency (TK2d) aged ≤12 years at TK2d symptom onset. Disease course of patients aged >12 years at TK2d symptom onset is reported separately (abstract 2629).
Authors
- Yuanjun Ma (ORCID: https://orcid.org/0009-0005-4806-0584)
- Susan VanMeter
- A. Nascimento Osorio
- Nada Boudiaf
- Cristina Domínguez‐González (ORCID: https://orcid.org/0000-0001-5151-988X)
- Marcus Brunnert
- Richard Kim
- Michio Hirano (ORCID: https://orcid.org/0000-0002-7070-7402)
Institutions
- Columbia University Irving Medical Center (US)
- Instituto de Salud Carlos III (ES)
- Centre for Biomedical Network Research on Rare Diseases (ES)
- UCB Pharma (Germany) (DE)
Publication Details
- Journal
- Neurology
- Published
- 2025-04-07
- DOI
- https://doi.org/10.1212/wnl.0000000000211173
- Citations
- 2
- Primary Topic
- Chronic Lymphocytic Leukemia Research
- Type
- article
- Field-Weighted Citation Impact
- 3.25